BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Afsar NA, Bruckmueller H, Werk AN, Nisar MK, Ahmad HR, Cascorbi I. Implications of genetic variation of common Drug Metabolizing Enzymes and ABC Transporters among the Pakistani Population. Sci Rep 2019;9:7323. [PMID: 31086207 DOI: 10.1038/s41598-019-43736-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Sileshi T, Mekonen G, Makonnen E, Aklillu E. Effect of Genetic Variations in Drug-Metabolizing Enzymes and Drug Transporters on the Pharmacokinetics of Rifamycins: A Systematic Review. PGPM 2022;Volume 15:561-71. [DOI: 10.2147/pgpm.s363058] [Reference Citation Analysis]
2 Khan AR, Shah SH, Ajaz S, Firasat S, Abid A, Raza A. The Prevalence of Pharmacogenomics Variants and Their Clinical Relevance Among the Pakistani Population. Evol Bioinform Online 2022;18:117693432210958. [DOI: 10.1177/11769343221095834] [Reference Citation Analysis]
3 Sun Z, He L, Yang Q, Zhang H, Xu W, Qin X, Liu G, Hu Z, Zhang L, Liu C. Study on the Effect of Three CYP2C9 Variants on Drug–Drug Interaction Related to Six Drugs In Vitro by LC–MS/MS Method. Chromatographia. [DOI: 10.1007/s10337-021-04126-8] [Reference Citation Analysis]
4 Ahmed S, Gul S, Akhlaq M, Hussain A, Tariq Khan S, Rehman H, Hanif Bangash M, Al Mughairbi F, Hamid Hamdard M. Estimation of polymorphisms in the drug-metabolizing enzyme, cytochrome P450 2C19 gene in six major ethnicities of Pakistan. Bioengineered 2021;12:4442-51. [PMID: 34308762 DOI: 10.1080/21655979.2021.1955809] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Chen R, Wang T, Song J, Pu D, He D, Li J, Yang J, Li K, Zhong C, Zhang J. Antiviral Drug Delivery System for Enhanced Bioactivity, Better Metabolism and Pharmacokinetic Characteristics. Int J Nanomedicine 2021;16:4959-84. [PMID: 34326637 DOI: 10.2147/IJN.S315705] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Micaglio E, Locati ET, Monasky MM, Romani F, Heilbron F, Pappone C. Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine. Front Pharmacol 2021;12:651720. [PMID: 33995067 DOI: 10.3389/fphar.2021.651720] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Koopmans AB, Braakman MH, Vinkers DJ, Hoek HW, van Harten PN. Meta-analysis of probability estimates of worldwide variation of CYP2D6 and CYP2C19. Transl Psychiatry 2021;11:141. [PMID: 33627619 DOI: 10.1038/s41398-020-01129-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
8 Gretler SR, Finno CJ, Kass PH, Knych HK. Functional phenotyping of the CYP2D6 probe drug codeine in the horse. BMC Vet Res 2021;17:77. [PMID: 33581736 DOI: 10.1186/s12917-021-02788-y] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Wang T, Zhou Y, Cao G. Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes. Eur J Clin Pharmacol 2021;77:1095-111. [PMID: 33515076 DOI: 10.1007/s00228-021-03088-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Rehman MYA, Taqi MM, Hussain I, Nasir J, Rizvi SHH, Syed JH. Elevated exposure to polycyclic aromatic hydrocarbons (PAHs) may trigger cancers in Pakistan: an environmental, occupational, and genetic perspective. Environ Sci Pollut Res Int 2020;27:42405-23. [PMID: 32875453 DOI: 10.1007/s11356-020-09088-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
11 Khidri FF, Waryah YM, Ali FK, Shaikh H, Ujjan ID, Waryah AM. MTHFR and F5 genetic variations have association with preeclampsia in Pakistani patients: a case control study. BMC Med Genet 2019;20:163. [PMID: 31646966 DOI: 10.1186/s12881-019-0905-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]